Group One Trading
SUPN icon

Group One Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Group One Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-331
Closed -$16.9K – 8704
2025
Q4 		$16.5K Sell
331
-2,459
-88% -$120K ﹤0.01% 6501
2025
Q3 		$133K Buy
+2,790
New +$112K ﹤0.01% 5076
2024
Q1 		– Sell
-852
Closed -$24.7K – 7943
2023
Q4 		$24.7K Buy
+852
New +$22.6K ﹤0.01% 5585
2023
Q2 		– Sell
-113
Closed -$4.09K – 8191
2023
Q1 		$4.09K Sell
113
-1,386
-92% -$53.3K ﹤0.01% 6365
2022
Q4 		$53.5K Sell
1,499
-29,197
-95% -$1.01M ﹤0.01% 4941
2022
Q3 		$1.04M Sell
30,696
-30,576
-50% -$995K ﹤0.01% 2549
2022
Q2 		$1.77M Buy
61,272
+59,984
+4,657% +$1.72M ﹤0.01% 2168
2022
Q1 		$42K Sell
1,288
-1,200
-48% -$36.8K ﹤0.01% 6238
2021
Q4 		$73K Sell
2,488
-1,851
-43% -$56.2K ﹤0.01% 6010
2021
Q3 		$116K Buy
+4,339
New +$116K ﹤0.01% 5762
2021
Q2 		– Sell
-1,584
Closed -$48.6K – 8567
2021
Q1 		$41K Buy
1,584
+839
+113% +$23.5K ﹤0.01% 6364
2020
Q4 		$19K Sell
745
-517
-41% -$11.1K ﹤0.01% 5556
2020
Q3 		$26K Sell
1,262
-10,288
-89% -$233K ﹤0.01% 5011
2020
Q2 		$274K Sell
11,550
-11,376
-50% -$251K ﹤0.01% 3127
2020
Q1 		$412K Sell
22,926
-58,334
-72% -$1.23M ﹤0.01% 2193
2019
Q4 		$1.93M Buy
81,260
+70,842
+680% +$1.72M 0.01% 1310
2019
Q3 		$286K Buy
10,418
+5,204
+100% +$154K ﹤0.01% 2807
2019
Q2 		$173K Sell
5,214
-260
-5% -$8.91K ﹤0.01% 2970
2019
Q1 		$192K Sell
5,474
-10,883
-67% -$405K ﹤0.01% 2740
2018
Q4 		$543K Buy
16,357
+14,165
+646% +$609K ﹤0.01% 1941
2018
Q3 		$110K Buy
+2,192
New +$108K ﹤0.01% 3467
2018
Q1 		– Sell
-456
Closed -$19K – 5288
2017
Q4 		$18K Sell
456
-452
-50% -$17.9K ﹤0.01% 4188
2017
Q3 		$36K Buy
+908
New +$39.3K ﹤0.01% 3795
2017
Q1 		– Sell
-7,471
Closed -$200K – 4984
2016
Q4 		$189K Buy
+7,471
New +$167K ﹤0.01% 2467
2016
Q2 		– Sell
-8,986
Closed -$159K – 4935
2016
Q1 		$137K Buy
+8,986
New +$117K ﹤0.01% 2601
2014
Q3 		– Sell
-89,882
Closed -$812K – 5453
2014
Q2 		$984K Sell
89,882
-239,919
-73% -$2.14M 0.02% 1149
2014
Q1 		$2.95M Buy
329,801
+130,528
+66% +$1.2M 0.05% 441
2013
Q4 		$1.5M Buy
+199,273
New +$1.39M 0.02% 821

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's SUPN Position: Q1 2026 in Review

Group One Trading sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 331 shares — an estimated $16.9K sold.

Group One Trading first reported a position in SUPN in Q4 2013 and held it in 28 quarters. The position peaked at $2.95M in Q1 2014. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Group One Trading reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 331 Supernus Pharmaceuticals shares in Q1 2026, an estimated $16.9K.
  • Group One Trading first reported a position in Supernus Pharmaceuticals in Q4 2013 and held it in 28 quarters.
  • Group One Trading's Supernus Pharmaceuticals position peaked at $2.95M in Q1 2014.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.